8-K
filed April 19, 2023, 7:59 PM ET
ticker ATEC
CIK 0001350653
M&A
confidence high
sentiment positive
materiality 0.80
Alphatec Holdings, Inc. (ATEC): M&A transaction — Alphatec acquires REMI robotic navigation system for $55M; raises FY2023 revenue guidance to $450M
Alphatec Holdings, Inc.
- Acquired REMI Robotic Navigation System assets for $55M cash from Integrity Implants and Fusion Robotics.
- Preliminary Q1 2023 total revenue $108-109.5M (+52% YoY); surgical revenue $93.2-94.3M (+53%).
- Full-year 2023 revenue guidance raised to $450M (from $438M); surgical revenue expected ~$393M.
- Cash and equivalents $117M as of March 31, 2023, up from $85M at Dec 31, 2022.
- Granted 22,741 RSUs to eighteen new non-executive employees as inducement awards.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Alphatec Holdings, Inc. reported full-year 2023 results: revenue $450 million. Guidance raised.
- Period
- full-year 2023
- Revenue
- $450 million
- Guidance
- raised
- Result
- guidance update
Exact text from the filing
The Company now anticipates full-year 2023 total revenue of $450 million compared to a prior expectation of $438 million, reflecting growth of approximately 28% year-over-year.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Alphatec Holdings, Inc. reported first quarter ended March 31, 2023 results: revenue expected range of between $108.0 million and $109.5 million. Guidance reaffirmed.
- Period
- first quarter ended March 31, 2023
- Revenue
- expected range of between $108.0 million and $109.5 million
- Guidance
- reaffirmed
- Result
- preliminary results
Exact text from the filing
Preliminary Financial Results The Company’s preliminary total revenue for the first quarter ended March 31, 2023 grew over 52% year-over-year to an expected range of between $108.0 million and $109.5 million. Preliminary surgical revenue grew for the first quarter ended March 31, 2023 over 53% to an expected range of between $93.2 million and $94.3 million, led by
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
Alphatec Holdings, Inc. completed an acquisition involving Integrity Implants Inc. and Fusion Robotics, LLC (the Sellers) and stockholders of Integrity for $55,000,000 (closed 2023-04-19).
- Action
- acquisition
- Counterparty
- Integrity Implants Inc. and Fusion Robotics, LLC (the Sellers) and stockholders of Integrity
- Consideration
- $55,000,000
- Closing
- 2023-04-19
Exact text from the filing
of the Asset Transaction. As consideration for the purchase of the REMI Business assets in the Asset Transaction, Spine agreed to pay to the Sellers cash consideration of $55,000,000. The Asset Transaction was also consummated on April 19, 2023. The REMI (Robotic-Enabled Minimally Invasive) System is an intra-operative platform developed by spine experts with
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.99
Alphatec Holdings, Inc. entered into Asset Purchase Agreement with Integrity Implants Inc. and Fusion Robotics, LLC valued at $55,000,000 cash consideration (effective 2023-04-19).
- Action
- entry
- Agreement
- asset purchase
- Counterparty
- Integrity Implants Inc. and Fusion Robotics, LLC
- Value
- $55,000,000 cash consideration
- Effective
- 2023-04-19
Exact text from the filing
On April 19, 2023, Alphatec Spine, Inc., a California corporation (“ Spine ”) and wholly owned subsidiary of Alphatec Holdings, Inc., a Delaware corporation (the “ Company ”), Integrity Implants Inc., a Delaware corporation (“ Integrity ”), Fusion Robotics, LLC, a Delaware limited liability company (“ Fusion ” and together with Integrity, collectively, the “ Sellers ”) and wholly owned subsidiary of Integrity, and stockholders of Integrity identified on Schedule A of the Purchase Agreement (as defined below) (the “ Key Stockholders ”) entered into an Asset Purchase Agreement (the “ Purchase Agreement ”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.